A new study suggests that semaglutide, the active ingredient in Ozempic, may help decrease liver fat, inflammation, and ...

Stocks closed solidly higher on Friday, pushing major indexes to big weekly gains for the third time in the last four weeks.

Novo Nordisk CEO's ouster signals stiff competition in the obesity market, getting dominated by Eli Lilly, with Roche, ...

Semaglutide is sold as Ozempic to treat Type 2 diabetes and ... Among the regular drinkers, consumption declined from 23.2 to 7.8 drinks a week. This graphic from the study shows the correlation ...

Ozempic and Wegovy maker Novo Nordisk ousted CEO Lars Fruergaard Jorgensen on Friday over concerns the company is losing its ...

Ozempic is a prescription drug used to deal with conditions related to high blood sugar levels and for diabetes management.

The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH.

Drug manufacturer Eli Lilly announced this week ... or nearly 8% of their body weight. This level of weight loss is consistent with the amount shed over the same period using Ozempic.

They were prescribed either semaglutide (Ozempic, Wegovy ... intake decreased from 23.2 units per week to 7.8 units. The reduction of 68 per cent is comparable to that achieved by nalmefene ...

The global market for Ozempic, Wegovy and similar drugs is projected to explode during the next five years. Fashion - which ...

The FDA and Novo Nordisk (the manufacturer of Ozempic) issued press releases early last week regarding several hundred ... care team at 1-800-727-6500 (8:30 a.m. to 6:00 p.m. EST, Monday through ...

showed they lost about seven kilograms – or nearly 8 per cent of their body weight – over 40 weeks. That compares favourably with Novo Nordisk’s injected drug Ozempic, where diabetic ...